Trump’s new drug price order sparks industry outrage

Monday, May 12, 2025, 8:20 am

President Trump’s latest order to adjust drug prices—targeting select Medicare-covered infusions—has ignited a chorus of criticism from pharmaceutical giants. The initiative, promising lower costs on paper, is already under fire for its potential disruptive impact, leaving industry insiders rolling their eyes at the regulatory maneuver.

ledevoir.com / Trump promet de réduire drastiquement le prix des médicaments

Le président américain a promis à ses concitoyens des baisses pouvant aller jusqu’à 90%.

nationalpost.com / Trump sets 30-day deadline for drugmakers to lower drug costs

Trump's promised new — but uncertain — savings on drug prices, just hours after the Republican-led House released its new plan to trim $880 billion from Medicaid

globalnews.ca / Trump looks to cut drug prices to match other countries with new order

Trump's proposal would likely only impact certain drugs covered by Medicare and given in an office — think infusions that treat cancer, and other injectables.

citynews.ca / Pharmaceutical industry criticizes the drug pricing plan Trump says he’ll sign

WASHINGTON (AP) — President Donald Trump’s plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he’s even signed the executive order set for Monday that, if implemented, could lower the cost of some drugs. Trump has…

permalink / 4 stories from sources in 20 days ago #business #republican #trump #health

More Top Stories...

Premiers and Carney Clash Over Nation-Building Priorities in Saskatoon

Provincial leaders met with Prime Minister Carney in Saskatoon, presenting bold wish lists centered on resource projects and infrastructure. The meeting underscored a spirited debate over national development priorities, with each region advocating its vision amid a backdrop of economic and policy negotiations. More...

Canada-U.S. Trade Talks Under Scrutiny Amid Calls for Openness

As Canada’s delegation prepares for a high-stakes encounter with its southern neighbor, political voices are dividing over the pace and transparency of the trade negotiations. One camp criticizes a lack of clarity while another expresses hope for meaningful tariff cuts ahead of imminent high-level discussions. More...

Canadian Metals React as Trump's Steel Tariffs Threaten Jobs

Amid concerns over U.S. tariff policies, Canadian metals advocates and local leaders have strongly critiqued President Trump’s decision to impose steep duties on steel and aluminium. The tariffs are blamed for jeopardizing jobs and creating economic uncertainty in Canada’s vital manufacturing sectors. More...

Ontario Councillors Resist Expanded Mayoral Powers in Municipalities

Local municipal leaders are pushing back against the provincial government’s decision to extend strong mayor powers to smaller towns. Councillors argue that centralizing authority undermines local control and democratic processes, with critics warning of unintended consequences from a one-size-fits-all approach. More...

B.C. Premier Eby Departs on Asia Trade Mission

British Columbia’s premier has set off on an Asian trade mission amid domestic controversy over fast‐tracked laws. Despite Indigenous leaders withdrawing their support, Eby remains focused on securing new economic opportunities for the province. The trip aims to forge stronger international ties and boost trade relations. More...

Related Tags

Trump’s new drug price order sparks industry outrage

More Top Stories...

Premiers and Carney Clash Over Nation-Building Priorities in Saskatoon

Canada-U.S. Trade Talks Under Scrutiny Amid Calls for Openness

Canadian Metals React as Trump's Steel Tariffs Threaten Jobs

Ontario Councillors Resist Expanded Mayoral Powers in Municipalities

B.C. Premier Eby Departs on Asia Trade Mission

Related Tags

Business

Republican Party

Trump

Health